[ Price : $8.95]
A new final rule outlines five standards that the agency says drug marketers must follow to ensure their direct-to-consumer advert...[ Price : $8.95]
Bayer stops its Phase 3 OCEANIC-AF study evaluating asundexian compared to apixaban (Bristol-Myers Squibbs Eliquis) in patients wi...[ Price : $8.95]
FDA warns healthcare professionals not to use Cardinal Health Monoject syringes with syringe pumps and patient-controlled analgesi...[ Price : $8.95]
Janssen Pharmaceutical files a supplemental BLA for Rybrevant (amivantamab-vmjw) in combination with chemotherapy (carboplatin and...[ Price : $8.95]
FDA issues Dr. Reddys Laboratories a 10-item Form FDA-483 after an inspection 10/27 at the firms Telangana, India manufacturing fa...[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Notifying FDA of a Permanent Discontinuance or Interruption...[ Price : $8.95]
Federal Register notice: FDA announces a 2/6/2024 advisory committee meeting on medical device supply chain resiliency and shortag...[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Assessing the Credibility of Computational Modeling and Sim...